The FDA has approved a first-of-its-kind treatment for dry age-related macular degeneration (AMD), a leading cause of blindness in adults over 55.

Theoretical mean number of injections per year based on monthly ... Comparison of Age-Related Macular Degeneration Treatment Trials; IVAN: A Randomized Controlled Trial of Alternative Treatments ...

Korean scientists have developed a revolutionary eye drop treatment for dry age-related macular degeneration (AMD), ...

Macular degeneration is a leading cause of vision loss, especially in people over the age of 50. It affects the macula, a ...

Toll-like receptors (TLRs) are vital components of the immune system, acting as sentinels that detect and respond to ...

Pravin U. Dugel, MD, Ocular’s Executive Chairman, President and CEO, will provide an update regarding the enrollment status of SOL-R, the Company’s second registrational trial of AXPAXLI™ for the ...

A new eye drop therapy offers a non-invasive alternative for treating dry age-related macular degeneration. Massively ...

Since July 2024, faricimab has also been approved in Europe for the treatment of visual impairment due to macular oedema ...

Shares of Outlook Therapeutics jumped after the company said it continues to progress the development of its treatment for wet age-related macular degeneration, which causes blurred or reduced ...

They can perform tests like optical coherence tomography (OCT) and recommend treatments such as lifestyle adjustments, vitamins, or medical interventions like injections to help preserve vision. At ...